Anda belum login :: 16 Apr 2025 07:18 WIB
Detail
ArtikelInhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin  
Oleh: Imesch, Patrick ; Samartzis, Eleftherios P. ; Schneider, Michael ; Fink, Daniel ; Fedier, Andre
Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Fertility and Sterility (keterangan: ada di ClinicalKey) vol. 95 no. 05 (Apr. 2011), page 1579-1583.
Topik: ENDOMETRIOSIS; HIF-1a; human epithelial endometriotic cells; romidepsin; VEGF expression and secretion
Ketersediaan
  • Perpustakaan FK
    • Nomor Panggil: F02.K.2011.03
    • Non-tandon: 1 (dapat dipinjam: 0)
    • Tandon: tidak ada
    Lihat Detail Induk
Isi artikelObjective To investigate whether the histone deacetylase (HDAC) inhibitor romidepsin down-regulates VEGF (vascular endothelial growth factor) gene expression and abrogates VEGF protein secretion in human epithelial endometriotic cells. Design In vitro study with human immortalized epithelial endometriotic cells. Setting University hospital. Patient(s) Not applicable. Intervention(s) None. Main Outcome Measure(s) Real-time reverse-transcriptase polymerase chain reaction to evaluate VEGF gene expression, immunoblot analysis to evaluate protein expression, and enzyme-linked immunosorbent assay to evaluate VEGF protein secretion into the culture medium. Result(s) Treatment of 11z human endometriotic cells with romidepsin statistically significantly inhibited VEGF gene transcription and down-regulated VEGF protein expression. Moreover, romidepsin abrogated the secretion of VEGF protein into the culture medium. Romidepsin also reduced the expression of hypoxia-inducible factor-1a (HIF-1a), which is implicated in the transcription of the VEGF gene, in cobalt chloride-pretreated (to mimic hypoxic conditions) 11z cultures. Conclusion(s) Romidepsin targets VEGF at the transcriptional level, which subsequently leads to the reduction of secreted VEGF (the “active” form of VEGF). Therefore, romidepsin may be a potential therapeutic candidate against angiogenesis in endometriosis.
Opini AndaKlik untuk menuliskan opini Anda tentang koleksi ini!

Kembali
design
 
Process time: 0 second(s)